Emmaus Life Sciences Total Assets 2006-2021 | EMMA

Emmaus Life Sciences total assets from 2006 to 2021. Total assets can be defined as the sum of all assets on a company's balance sheet.
Emmaus Life Sciences Annual Total Assets
(Millions of US $)
2020 $60
2019 $59
2018 $75
2018 $5
2017 $6
2016 $1
2015 $1
2014 $1
2013 $1
2012 $0
2011 $0
2010 $0
2009 $1
2008 $3
2007 $0
2007 $6
2006 $6
Emmaus Life Sciences Quarterly Total Assets
(Millions of US $)
2021-09-30 $60
2021-06-30 $63
2021-03-31 $62
2020-12-31 $60
2020-09-30 $60
2020-06-30 $66
2020-03-31 $66
2019-12-31 $59
2019-09-30 $56
2019-06-30 $4
2019-03-31 $3
2018-12-31 $75
2018-09-30 $5
2018-06-30 $5
2018-03-31 $5
2017-12-31 $5
2017-09-30 $6
2017-06-30 $1
2017-03-31 $2
2016-12-31 $2
2016-09-30 $1
2016-06-30 $1
2016-03-31 $1
2015-12-31 $1
2015-09-30 $1
2015-06-30 $0
2015-03-31 $0
2014-12-31 $1
2014-09-30 $1
2014-06-30 $0
2014-03-31 $1
2013-12-31 $1
2013-09-30 $1
2013-06-30 $1
2013-03-31 $1
2012-12-31 $1
2012-09-30 $0
2012-06-30 $0
2012-03-31 $1
2011-12-31 $0
2011-09-30 $0
2011-06-30 $1
2011-03-31 $1
2010-12-31 $1
2010-09-30 $0
2010-06-30 $0
2010-03-31 $1
2009-12-31 $2
2009-09-30 $1
2009-06-30 $1
2009-03-31 $1
2008-12-31 $2
2008-09-30 $3
2008-06-30 $4
2008-03-31 $5
2007-12-31 $5
2007-09-30 $6
2007-06-30 $7
2007-03-31 $7
2006-12-31 $6
2006-09-30 $0
2006-06-30 $0
2006-03-31 $0
2005-09-30 $0
2005-06-30 $0
2005-03-31 $0
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.076B $0.023B
Emmaus Life Sciences Inc. is a commercial-stage biopharmaceutical company. It is engaged in the discovery, development, marketing and sale of treatments and therapies, for rare and orphan disease categories. Emmaus Life Sciences Inc., formerly known MYnd Analytics Inc., is based in Torrance, United States.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $125.010B 7.90
Bio-Rad Laboratories (BIO.B) United States $22.443B 45.55
QIAGEN (QGEN) Netherlands $12.357B 20.93
Biohaven Pharmaceutical Holding (BHVN) United States $6.783B 0.00
Arcus Biosciences (RCUS) United States $3.105B 0.00
Emergent Biosolutions (EBS) United States $2.254B 8.10
ADC Therapeutics SA (ADCT) Switzerland $1.478B 0.00
Myovant Sciences (MYOV) United Kingdom $1.368B 0.00
Zymeworks (ZYME) Canada $0.861B 0.00
Ambrx Biopharma (AMAM) United States $0.337B 0.00
SQZ Biotechnologies (SQZ) United States $0.319B 0.00
Enzo Biochem (ENZ) United States $0.162B 15.90